earnings
confidence high
sentiment positive
materiality 0.75
GoodRx Q2 revenue $200.4M, Pharma Direct +76% YoY; raises FY2026 guidance
GoodRx Holdings, Inc.
- Revenue $200.4M; net income $8.5M (4.3% margin); adjusted EBITDA $63.7M (31.8% margin).
- Pharma Direct revenue up 76% YoY; Subscription revenue up 39% YoY.
- Company raises full-year 2026 revenue and adjusted EBITDA expectations.
- Adjusted net income $26.8M (13.4% margin); net cash from operations $80.8M.